Aprea Therapeutics Inc expected to post a loss of 37  cents a share - Earnings Preview

Aprea Therapeutics

08/08/2022 12:18

* Aprea Therapeutics Inc  APRE.OQ   APRE.O  is expected
to show no
change in quarterly revenue when it reports  results on August
10 (estimated). 
    * ​Refinitiv's mean analyst estimate for Aprea Therapeutics
Inc is
for a loss of 37 cents per share. For the same quarter last
year, the company reported a loss of 48 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $2.5​, above​ its last closing price
of $0.99. ​​​

This summary was machine generated August 8 at 11:17 GMT.  All
figures in US dollars  unless otherwise stated